Clean shooters
Visible Particle Inspection Device[edit | edit source]
Problem Statement: To design and build an inspection device that will detect particles present in fluid contained in both 2.25mL and 10mL glass syringes as well cracks in the syringes themselves.
Team Members[edit | edit source]
- Nick Rodriguez (Electrical Engineering Student)
- Hails from Pocatello, Idaho.
- Nate Pueschel (Mechanical Engineering Student)
- Hails from Boise, Idaho.
- Justin Herrick (Mechanical Engineering Student)
- Hails from Eagle River, Alaska.
- Greg Atkinson (Mechanical Engineering Student)
- Hails from Gig Harbor, Washington.
Project Description[edit | edit source]
Outcome
- The device needs to clearly display a pass/fail indication for each syringe inspected so that the operator can separate the 'good' syringes from the 'bad'.
Passing Requirements
- No visible cracks on the glass
- No particles over 40 microns (Human eye smallest viewing)
- Proper level of head space between the liquid and the stopper
Specifications
- Under 2' by 3' base dimension
- Approximately inspects one syringe/second
- Clear, easy to understand, pass/fail indications
- Must operate in refrigerated environment (5°C ± 3°C)
- LED lighting that provides good contrasts
Current Rough Concept[edit | edit source]
Main Ideas
- Two stations so that the machine can be running at all times
- Fully automated so that there is little human factor involved
- Use a Micro-controller to be the brains of the operation
- Camera to take pictures of the syringes
- Those pictures will run through an analysis program to determine if the syringes are clean
- LED lights will show if the syringes are clean or not
- Loading station to unload/load the syringes
Technology and Software[edit | edit source]
- Small compact GigE Vision camera, Genie TS-M4096
- ATS Smartvision Softare
- Cerbot MicroController
Sponsor[edit | edit source]
Revalesio Corporation is a pioneering biotechnology company based in Tacoma, Washington, dedicated to restoring hope and transforming lives.
"Our goal is to maximize the benefits of our novel technology by developing products that represent a potential new class of treatments for inflammatory mediated diseases. To that end, Revalesio has partnered with leaders in biomedical research as well as non-profit organizations around the world, to help us deliver on our promise to bring hope to people around the globe."